SRP4580
BMP-14 (GDF-5/CDMP-1) human
recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC)
Manufacturer: Sigma Aldrich
Synonym(S): BMP-14/ CDMP-1, Cartilage derived morphogenetic protein-1, GDF-5, bone morphogenetic protein 14
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 50 μG | SRP4580-50-μG | In Stock | ₹ 34,943.10 |
SRP4580 - 50 μG
In Stock
Quantity
1
Base Price: ₹ 34,943.10
GST (18%): ₹ 6,289.758
Total Price: ₹ 41,232.858
biological source
human
recombinant
expressed in E. coli
Assay
≥98% (HPLC)≥98% (SDS-PAGE)
form
lyophilized
potency
0.5-4 μg ED50
mol wt
~27 kDa
packaging
pkg of 50 μg
storage condition
avoid repeated freeze/thaw cycles
impurities
endotoxin, tested
NCBI accession no.
X80915
Related Products
Description
- General description: The gene BMP-14 (bone morphogenetic protein 14) is mapped to human chromosome 20q11.22.[1] It belongs to the bone morphogenetic protein family.[2] Recombinant human BMP-14 is a 27kDa homodimeric protein consisting of two 120 amino acid polypeptide chains.
- Biochem/physiol Actions: BMP-14 (bone morphogenetic protein 14) is involved in enhancing proliferations of osteoblasts, periosteum cells and connective tissue fibroblasts. It also promotes endochondral bone growth, proper development of limb skeletons and joints, and odontogenesis. It interacts with BMP type II receptor (BMPR-II) and might be involved in bone morphogenesis.[2] Mutations in the BMP-14 gene are associated with brachydactyly type C, intervertebral disc degeneration, acromesomelic dysplasia Grebe type and osteoarthritis.[3][4][5][1]
- Physical form: Lyophilized from 10 mM Sodium Citrate, pH 3.5.
- Reconstitution: Centrifuge the vial prior to opening. Avoid freeze-thaw cycles.
SAFETY INFORMATION
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Compare Similar Items
Show Difference
biological source: human
recombinant: expressed in E. coli
Assay: ≥98% (HPLC)≥98% (SDS-PAGE)
form: lyophilized
potency: 0.5-4 μg ED50
mol wt: ~27 kDa
packaging: pkg of 50 μg
storage condition: avoid repeated freeze/thaw cycles
impurities: endotoxin, tested
NCBI accession no.: X80915
biological source:
human
recombinant:
expressed in E. coli
Assay:
≥98% (HPLC)≥98% (SDS-PAGE)
form:
lyophilized
potency:
0.5-4 μg ED50
mol wt:
~27 kDa
packaging:
pkg of 50 μg
storage condition:
avoid repeated freeze/thaw cycles
impurities:
endotoxin, tested
NCBI accession no.:
X80915
biological source: human
recombinant: expressed in E. coli
Assay: ≥95% (HPLC)≥95% (SDS-PAGE)
form: lyophilized
potency: 1x10^8 units/mg
mol wt: ~19.3 kDa
packaging: pkg of 100 μg
storage condition: avoid repeated freeze/thaw cycles
impurities: endotoxin, tested
NCBI accession no.: NM_024013
biological source:
human
recombinant:
expressed in E. coli
Assay:
≥95% (HPLC)≥95% (SDS-PAGE)
form:
lyophilized
potency:
1x10^8 units/mg
mol wt:
~19.3 kDa
packaging:
pkg of 100 μg
storage condition:
avoid repeated freeze/thaw cycles
impurities:
endotoxin, tested
NCBI accession no.:
NM_024013
biological source: human
recombinant: expressed in E. coli
Assay: ≥90% (SDS-PAGE)
form: lyophilized
potency: __
mol wt: 15-16 kDa
packaging: pkg of 10 μg
storage condition: avoid repeated freeze/thaw cycles
impurities: endotoxin, tested
NCBI accession no.: Q6FH59
biological source:
human
recombinant:
expressed in E. coli
Assay:
≥90% (SDS-PAGE)
form:
lyophilized
potency:
__
mol wt:
15-16 kDa
packaging:
pkg of 10 μg
storage condition:
avoid repeated freeze/thaw cycles
impurities:
endotoxin, tested
NCBI accession no.:
Q6FH59
biological source: human
recombinant: expressed in E. coli
Assay: ≥95% (SDS-PAGE)
form: lyophilized
potency: 0.5-4 μg/mL ED50 (determined by its ability to induce alkaline phosphatase production by ATDC-5 chondrogenic cells.)
mol wt: ~27 kDa
packaging: pkg of 50 μg
storage condition: avoid repeated freeze/thaw cycles
impurities: endotoxin, tested
NCBI accession no.: Q6KF10
biological source:
human
recombinant:
expressed in E. coli
Assay:
≥95% (SDS-PAGE)
form:
lyophilized
potency:
0.5-4 μg/mL ED50 (determined by its ability to induce alkaline phosphatase production by ATDC-5 chondrogenic cells.)
mol wt:
~27 kDa
packaging:
pkg of 50 μg
storage condition:
avoid repeated freeze/thaw cycles
impurities:
endotoxin, tested
NCBI accession no.:
Q6KF10